SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-006525
Filing Date
2022-03-10
Accepted
2022-03-10 16:45:46
Documents
110
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form-10k.htm   iXBRL 10-K 2860557
2 ex4-1.htm EX-4.1 175268
3 ex10-50.htm EX-10.50 78712
4 ex10-51.htm EX-10.51 379154
5 ex21-1.htm EX-21.1 10465
6 ex23-1.htm EX-23.1 2473
7 ex31-1.htm EX-31.1 19433
8 ex31-2.htm EX-31.2 18579
9 ex32-1.htm EX-32.1 7743
10 ex32-2.htm EX-32.1 7495
  Complete submission text file 0001493152-22-006525.txt   13880548

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE hrow-20211231.xsd EX-101.SCH 86929
12 XBRL CALCULATION FILE hrow-20211231_cal.xml EX-101.CAL 111008
13 XBRL DEFINITION FILE hrow-20211231_def.xml EX-101.DEF 442249
14 XBRL LABEL FILE hrow-20211231_lab.xml EX-101.LAB 693390
15 XBRL PRESENTATION FILE hrow-20211231_pre.xml EX-101.PRE 564584
104 EXTRACTED XBRL INSTANCE DOCUMENT form-10k_htm.xml XML 2494208
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35814 | Film No.: 22729678
SIC: 2834 Pharmaceutical Preparations